scispace - formally typeset
Open AccessJournal ArticleDOI

Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors.

Reads0
Chats0
TLDR
This research highlights the need to understand more fully the role of language in the development of post-graduate education and the role that language skills play in the decision-making process.
Abstract
The International Committee of Medical Journal Editors (ICMJE) believes there is an ethical obligation to responsibly share data generated by interventional clinical trials because trial participants have put themselves at risk. In January 2016 we published a proposal aimed at helping to create an environment in which the sharing of deidentified individual participant data becomes the norm. In response to our request for feedback we received many comments from individuals and groups. (1) Some applauded the proposals while others expressed disappointment they did not more quickly create a commitment to data sharing. Many raised valid concerns regarding the feasibility of the proposed requirements, the necessary resources, the real or perceived risks to trial participants, and the need to protect the interests of patients and researchers. It is encouraging that data sharing is already occurring in some settings. Over the past year, however, we have learned that the challenges are substantial and the requisite mechanisms are not in place to mandate universal data sharing at this time. Although many issues must be addressed for data sharing to become the norm, we remain committed to this goal. Therefore, ICMJE will require the following as conditions of consideration for publication of a clinical trial report in our member journals: i) As of July 1, 2018 manuscripts submitted to ICMJE journals that report the results of clinical trials must contain a data sharing statement as described below. ii) Clinical trials that begin enrolling participants on or after January 1, 2019 must include a data sharing plan in the trials registration. The ICMJE's policy regarding trial registration is explained at www.icmje.org/recommendations/browse/ publishing-and-editorial-issues/clinical-trial-registration.html. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. Data sharing statements must indicate the following: whether individual deidentified participant data (including data dictionaries) will be shared; what data in particular will be shared; whether additional, related documents will be available (e.g. study protocol, statistical analysis plan, etc.); when the data will become available and for how long; by what access criteria data will be shared (including with whom, for what types of analyses and by what mechanism). Illustrative examples of data sharing statements that would meet these requirements are in the Table 1. These initial requirements do not yet mandate data sharing, but investigators should be aware that editors may take into consideration data sharing statements when making editorial decisions. These minimum requirements are intended to move the research enterprise closer to fulfilling our ethical obligation to participants. Some ICMJE member journals already maintain, or may choose to adopt, more stringent requirements for data sharing. Sharing clinical trial data is one step in the process articulated by the World Health Organization (WHO) and other professional organizations as best practice for clinical trials: universal prospective registration; public disclosure of results from all clinical trials (including through journal publication); and data sharing. Although universal compliance with the requirement to prospectively register clinical trials has not yet been achieved and requires continued emphasis, we must work towards fulfilling the other steps of best practice as well-including data sharing. As we move forward into this new norm where data are shared, greater understanding and collaboration among funders, ethics committees, journals, trialists, data analysts, participants, and others will be required. We are currently working with members of the research community to facilitate practical solutions to enable data sharing. …

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

TL;DR: Dulaglutide could be considered for the management of glycaemic control in middle-aged and older people with type 2 diabetes with either previous cardiovascular disease or cardiovascular risk factors.
Journal ArticleDOI

Open science challenges, benefits and tips in early career and beyond

TL;DR: Key benefits are described, including reputational gains, increased chances of publication, and a broader increase in the reliability of research, which should benefit both the ECR and the quality of research.
Journal ArticleDOI

A simplified guide to randomized controlled trials

TL;DR: In this review, simple descriptive guidance on planning, conducting, analyzing and reporting randomized controlled trials is provided.
Journal ArticleDOI

Reproducible and replicable pain research: a critical review.

TL;DR: This review concludes that reproducible and replicable pain research: a critical review is warranted and the current state of research in this area needs to be improved.
References
More filters
Related Papers (5)